Zymeworks
ZYME
$8.76
Share price
2.10%
Change (1 day)
3.91%
Change (1 year)
Categories
P/S ratio for Zymeworks (ZYME)
P/S ratio as of May 2024 (TTM): 8.13
According to Zymeworks's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.13263. At the end of 2023 the company had a P/S ratio of 9.57.
P/S ratio history for Zymeworks from 2017 to 2021
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 9.57 | 697.1% |
| 2022 | 1.20 | -91.19% |
| 2021 | 13.6 | -75.57% |
| 2020 | 55.7 | -8.43% |
| 2019 | 60.9 | 587.58% |
| 2018 | 8.85 | 137.84% |
| 2017 | 3.72 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |